Covid 19 vaccine

The clinical trials of COVID-19 vaccine produced by Gamalei Institute of Epidemiology and Microbiology started on June 18

Phase III trials were likely to start “pretty soon,” and the company plans to recruit 40,000 participants for the tests

The experimental vaccine, which showed promise against the fast-spreading respiratory illness in early stage human testing, is…

The company said last month it would partner with US-based Refana Inc to make a potential COVID-19 vaccine, in a collaboration…

Moderna’s vaccine was among the first to be tested in humans in the United States and was found to produce protective antibodies…

Gorsky said it was a good thing other companies are experimenting with different approaches to vaccines, in part because different…

At the moment, it is the only one from India to adopt a triple-antigen approach that is designed to produce an enhanced immune…

Moderna also plans to start its late-stage trial this month

He was speaking during the launch of 'Compact XL, a compact diagnostics machine by MyLab Discovery Solutions, that will automate…

Sinovac Biotech’s experimental vaccine set to become the country’s second and the world’s third to enter final stage testing later…